MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy

Title:MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy

Volume: 6 Issue: 2

Author(s): Stefan R. Mazurek, Tyler Calway, Cynthia Harmon, Priyanka Farrell and Gene H. Kim*

Affiliation:

• Department of Medicine, University of Chicago, Chicago, IL 60637,United States

Keywords: Arrhythmia, cardiomyopathy, desmocollin 2, desmosome, intercalated disc, miR-130a.

Abstract: Background: MicroRNAs are small noncoding RNA molecules that play a critical role in regulating physiological and disease processes. Recent studies have now recognized microRNAs as an important player in cardiac arrhythmogenesis. Molecular insight into arrhythmogenic cardiomyopathy (AC) has primarily focused on mutations in desmosome proteins. To our knowledge, models of AC due to microRNA dysregulation have not been reported. Previously, we reported on miR-130a mediated down-regulation of Connexin43.

Objective: Here, we investigate miR-130a-mediated translational repression of Desmocollin2 (DSC2), as it has a predicted target site for miR-130a. DSC2 is an important protein for cell adhesion, which has been shown to be dysregulated in human AC.

Method & Results: After induction of miR-130a, transgenic mice demonstrated right ventricular dilation. Surface ECG revealed spontaneous premature ventricular complexes confirming an arrhythmogenic phenotype in αMHC-miR130a mice. Using total protein from whole ventricular lysate, western blot analysis demonstrated an 80% reduction in DSC2 levels in transgenic myocardium. Furthermore, immunofluorescent staining confirmed downregulation of DSC2 in transgenic compared with littermate control myocardium. In transgenic hearts, histologic findings revealed fibrosis and lipid accumulation within both ventricles. To validate DSC2 as a direct target of miR-130a, we performed in vitro target assays in 3T3 fibroblasts, known to express miR-130a. Using a luciferase reporter fused to the 3UTR of DSC2 compared with a control, we found a 42% reduction in luciferase activity with the DSC2 3UTR. This reduction was reversed upon selective inhibition of miR-130a.

Conclusion: Overexpression of miR-130a results in a disease phenotype characteristic of AC and therefore, may serve as potential model for microRNA-induced AC.

Cite this article as:

Mazurek R. Stefan, Calway Tyler, Harmon Cynthia, Farrell Priyanka and Kim H. Gene*, MicroRNA-130a Regulation of Desmocollin 2 in a Novel Model of Arrhythmogenic Cardiomyopathy, MicroRNA 2017; 6 (2) . https://dx.doi.org/10.2174/2211536605666161109111031

DOI https://dx.doi.org/10.2174/2211536605666161109111031	Print ISSN 2211-5366
Publisher Name Bentham Science Publisher	Online ISSN 2211-5374